Literature DB >> 19951184

CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.

Jose Manuel Lozano1, Rafael González, Juan Luque, Mario Frias, Antonio Rivero, Jose Peña.   

Abstract

It has been recently reported that CD8(+) T cells from healthy human peripheral blood express the tolerogenic HLA-G molecule originally described in trophoblasts. The majority of these CD8(+)HLA-G(+) cells exhibit a naïve phenotype and are FoxP3 negative, and they have been classified as a novel subset of regulatory T cells based on their potent suppressive function. We have investigated if this new cell population is expanded during HIV-1 infection. The results presented here show an increase in the percentage of CD8(+)HLA-G(+) cells within the total CD8 T-cell population in HIV-1(+) patients. As in healthy controls, these CD8(+)HLA-G(+) are mostly naïve T cells. However, we have also observed that only in HIV-1-infected patients are there effector and effector memory cells that express HLA-G.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951184     DOI: 10.1089/vim.2009.0041

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

Review 1.  Emerging topics and new perspectives on HLA-G.

Authors:  Enrico Fainardi; Massimiliano Castellazzi; Marina Stignani; Fabio Morandi; Gwenaëlle Sana; Rafael Gonzalez; Vito Pistoia; Olavio Roberto Baricordi; Etienne Sokal; Josè Peña
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

2.  Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.

Authors:  Jinghe Huang; Patrick Burke; Yue Yang; Katherine Seiss; Jill Beamon; Thai Cung; Ildiko Toth; Florencia Pereyra; Mathias Lichterfeld; Xu G Yu
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Effects on innate immunity of a therapeutic dendritic cell-based vaccine for HIV-1 infection.

Authors:  José Peña; Mario Frías; Laura Castro-Orgaz; Rafael González; Felipe García; Teresa Gallart; Jose María Gatell; Montserrat Plana
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

4.  The relationship of 3'UTR HLA-G14-bp insertion/deletion and +3142 C/G polymorphisms and soluble HLA-G expression with gynecological cancers: An updated meta-analysis.

Authors:  Kalthoum Tizaoui; Maroua Jalouli; Nadia Boujelbene; Abdel Halim Harrath; Hadda-Imene Ouzari; Roberta Rizzo; Inès Zidi
Journal:  Immun Inflamm Dis       Date:  2022-07

Review 5.  Mammalian non-classical major histocompatibility complex I and its receptors: Important contexts of gene, evolution, and immunity.

Authors:  B M Pratheek; Tapas K Nayak; Subhransu S Sahoo; Prafulla K Mohanty; Soma Chattopadhyay; Ntiya G Chakraborty; Subhasis Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2014-04

6.  Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection.

Authors:  Chun Li; Ilona Toth; Julian Schulze Zur Wiesch; Florencia Pereyra; Jennifer Rychert; Eric S Rosenberg; Jan van Lunzen; Mathias Lichterfeld; Xu G Yu
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

7.  Variation sites at the HLA-G 3' untranslated region confer differential susceptibility to HIV/HPV co-infection and aneuploidy in cervical cell.

Authors:  Fernanda Silva Medeiros; Albert Eduardo Silva Martins; Renan Garcia Gomes; Sávio Augusto Vieira de Oliveira; Stefan Welkovic; Magda Maruza; Maria Luiza Bezerra Menezes; Ricardo Arraes de Alencar Ximenes; George Tadeu Nunes Diniz; Eduardo Antônio Donadi; Norma Lucena-Silva
Journal:  PLoS One       Date:  2018-10-02       Impact factor: 3.240

Review 8.  HLA-G Expressing Immune Cells in Immune Mediated Diseases.

Authors:  P Contini; Giuseppe Murdaca; Francesco Puppo; Simone Negrini
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.